Towards Long-Living Metathesis Catalysts
NMR (376 MHz, [D6]acetone, 25 °C, TMS): δ = –76.2 (s,
CF3) ppm. HRMS (ESI): calcd. for C35H39ClF3N4O2Ru 741.1757
[M – Cl + CH3CN]+; found 741.1735. C33H36Cl2F3N3O2Ru
(735.64): calcd. C 53.73, H 5.19, N 5.67; found C 53.05, H 5.17, N
5.40.
Experimental Section
General: All reagents were used as received. Dichloromethane
(DCM) and toluene were dispensed from a solvent purification sys-
tem from Innovative Technology. The catalysts were synthesized in
an MBraun glove-box containing dry argon and less than 1 ppm
oxygen or on a Schlenk line according to previously described pro-
cedures. Complexes 1b,[7a] 1c,[9b] and 1d[10] were synthesized accord-
ing to previously described procedures. Flash column chromatog-
[1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene][2-isopropoxy-
5-(2,2,2-trifluoroacetamido)benzylidene]ruthenium(II) Chloride (6c):
Following the general procedure for complex 1c afforded the title
product (125 mg, 61% yield). 1H NMR (400 MHz, [D6]acetone,
25 °C, TMS): δ = 16.37 (s, 1 H, CH=Ru), 10.24 (s, 1 H, NH-CO),
7.92 [dd, 3J(H,H) = 8.9, 4J(H,H) = 2.5 Hz, 1 H, CHAr], 7.57 [t,
3J(H,H) = 7.7 Hz, 2 H, CHAr], 7.43 [d, 3J(H,H) = 7.7 Hz, 4 H,
raphy was performed on silica gel 60 (230–400 mesh). H, 13C and
1
19F NMR spectra were recorded with a Bruker Avance 400 Ultra-
shield NMR spectrometer. HRMS analyses were performed at the
ICIQ with a Waters LCT Premier or GCT mass spectrometer. Ele-
mental analyses were performed at the Universidad Complutense
de Madrid. The ICP-MS measurements were performed by the
UT2A Company, France. Substrates and products 8–21,[24b] 23–
31,[24b] 32,[34] 33,[15b] 34,[35] 35,[17] 36,[21] 37,[36] 40,[14a] 41,[37] 43,[28c]
and 44[38] have been described previously; for the others see the
Supporting Information.
4
3
CHAr], 7.31 [t, J(H,H) = 2.6 Hz, 1 H, CHAr], 7.11 [d, J(H,H) =
8.9 Hz, 1 H, CHAr], 5.03 [sept., 3J(H,H) = 6.1 Hz, 1 H, OCH-
(CH3)2], 4.32 (s, 4 H, CH2-CH2), 3.69 [sept., J(H,H) = 6.7 Hz, 1
3
H, CH(CH3)2NHC], 1.37 [d, 3J(H,H) = 6.1 Hz, 6 H, OCH-
(CH3)2], 1.28–1.22 (m, 24 H, CH3NHC) ppm. 13C NMR (100 MHz,
[D6]acetone, 25 °C, TMS): δ = 285.2 [d, J(C,Ru) = 12.3 Hz,
CH=Ru], 212.3 (NCN), 154.9 (CAr), 154.6 (CAr), 149.9 (NH-C=O),
149.1 (CAr), 144.0 (CAr), 137.0 (CAr), 131.2 (CAr), 131.1 (CAr),
129.6 (CHAr), 124.2 (CHAr), 121.3 (CHAr), 121.2 (CHAr), 116.1 [q,
J(C,F) = 285.6 Hz, CF3], 114.0 (CHAr), 113.9 (CAr), 113.2 (CHAr),
75.3 [OCH(CH3)2], 54.8 (CH2-CH2) 28.6 [CH(CH3)2NHC], 25.9
(CH3), 22.9 (CH3), 21.1 (CH3) ppm. 19F NMR (376 MHz,
[D6]acetone, 25 °C, TMS): δ = –76.2 (s, CF3) ppm. HRMS (ESI):
calcd. for C39H49F3N3O2Ru 750.2820 [M – Cl – HCl]+; found
750.2858. C39H50Cl2F3N3O2Ru (821.81): calcd. C 57.00, H 6.13, N
5.11; found C 56.67, H 6.09, N 5.03.
General Procedure for the Synthesis of the Catalysts: The styrenyl
ether ligand 7 (1 equiv.) in DCM solution (1 mL per 0.05 mmol of
ligand) was added to a solution of the Ru-based catalyst and cop-
per chloride (1.1 equiv.) in dry DCM (1 mL per 0.02 mmol of Ru
complex). The resulting mixture was stirred at 35 °C for 5 h. Vola-
tiles were removed under reduced pressure, acetone was added to
the residue, and the solution was filtered through a plug of Celite®.
The filtrate was concentrated and purified by chromatography on
silica gel (pentane/acetone, 75:25) to yield catalysts 6a–d as green
microcrystalline solids.
[1,3-Bis(2,6-diisopropylphenyl)-1H-imidazol-2(3H)-ylidene][2-iso-
propoxy-5-(2,2,2-trifluoroacetamido)benzylidene]ruthenium(II)
Chloride (6d): Following the general procedure for complex 1d af-
forded the title product (192 mg, 91% yield). H NMR (400 MHz,
[D6]acetone, 25 °C, TMS): δ = 16.47 (s, 1 H, CH=Ru), 7.94 [dt,
[1,3-Bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene][2-isopropoxy-
5-(2,2,2-trifluoroacetamido)benzylidene]ruthenium(II) Dichloride
(6a): Following the general procedure for complex 1a afforded the
title product (237 mg, 88 % yield). 1 H NMR (400 MHz,
[D6]acetone, 25 °C, TMS): δ = 16.44 (s, 1 H, CH=Ru), 7.79 [dd,
1
4
3
3J(H,H) = 8.9 Hz, J(H,H) = 2.6 Hz, 1 H, CHAr], 7.66 [t, J(H,H)
= 7.8 Hz, 2 H, CHAr], 7.63 (s, 2 H, CHNHC), 7.49 [d, 3J(H,H) =
8.9 Hz, 4 H, CHAr], 7.66 [t, 4J(H,H) = 2.6 Hz, 1 H, CHAr], 7.12 [d,
4
4
3J(H,H) = 8.8, J(H,H) = 2.5 Hz, 1 H, CHAr], 7.61 [d, J(H,H) =
2.6 Hz, 1 H, CHAr], 7.08–7.06 (m, 5 H, CHAr), 4.97 [sept., 3J(H,H)
= 6.1 Hz, 1 H, CH(CH3)2], 4.28 (s, 4 H, CH2-CH2), 2.47 (s, 12 H,
3J(H,H) = 8.9 Hz, 1 H, CHAr], 5.03 [sept., J(H,H) = 6.1 Hz, 1 H,
3
CH3ortho), 2.43 (s, 6 H, CH3para), 1.26 [d, J(H,H) = 6.1 Hz, 6 H,
3
OCH(CH3)2], 3.17 [sept, 3J(H,H) = 6.8 Hz, 1 H, CH(CH3)2NHC],
CH(CH3)2] ppm. 13C NMR (100 MHz, [D6]acetone, 25 °C, TMS):
δ = 291.3 [d, J(C,Ru) = 12.3 Hz, CH, CH=Ru], 209.9 (NCN), 149.5
(C=O), 145.0 (CAr), 138.7 (CAr), 131.3 (CAr), 129.1 (CHAr), 121.1
(CHAr), 121.0 (CHAr), 116.0 [q, J(C,F) = 286.7 Hz, CF3], 114.2
(CHAr), 114.1 (CHAr), 113.2 (CHAr), 75.3 [CH(CH3)2], 51.4 (CH2),
20.6 (CH3), 20.3 (CH3) ppm. 19F NMR (376 MHz, [D6 ]-
acetone, 25 °C, TMS): δ = –76.2 (s, CF3) ppm. HRMS (ESI): calcd.
for C35H41ClF3N4O2Ru 743.1914 [M+ – Cl+CH3CN]; found
743.1926. C33H38Cl2F3N3O2Ru (737.65): calcd. C 53.73, H 5.19, N
5.67; found C 53.81, H 5.30, N 5.64.
3
3
1.40 [d, J(H,H) = 6.1 Hz, 6 H, OCH(CH3)2], 1.22 [d, J(H,H) =
6.8 Hz, 12 H, CH3NHC], 1.17 [d, 3J(H,H) = 6.8 Hz, 12 H,
CH3NHC] ppm. 13C NMR (100 MHz, [D6]acetone, 25 °C, TMS): δ
= 282.5 [d, J(C,Ru) = 12.6 Hz, CH=Ru], 175.9 (NCN), 149.9
(C=O), 148.1 (CHAr), 144.6 (CAr), 136.3 (CAr), 131.4 (CAr), 130.4
(CHAr), 126.9 (CHAr), 123.8 (CHAr), 120.7 (CHAr), 123.8 (CHAr),
116.1 [q, J(C,F) = 286.5 Hz, CF3], 113.5 (CHAr), 113.2 (CHAr),
75.5 [OCH(CH3)2], 28.6 [CH(CH3)2NHC], 25.6 (CH3), 22.3 (CH3),
21.0 (CH3) ppm. 19F NMR (376 MHz, [D6]acetone, 25 °C, TMS): δ
= –76.1 (s, CF3) ppm. HRMS (ESI): calcd. for C39H48ClF3N3O2Ru
784.2431 [M – Cl]+; found 784.2497. C39H48Cl2F3N3O2Ru (819.80):
calcd. C 57.14, H 5.90, N 5.13; found C 56.81, H 5.86, N 5.07.
[1,3-Dimesityl-1H-imidazol-2(3H)-ylidene][2-isopropoxy-5-(2,2,2-tri-
fluoroacetamido)benzylidene]ruthenium(II) Chloride (6b): Following
the general procedure for complex 1b afforded the title product
(110 mg, 82 % yield). 1H NMR (400 MHz, [D6]acetone, 25 °C,
TMS): δ = 16.57 (s, 1 H, CH=Ru), 7.80 [dd, 3J(H,H) = 9.0 Hz,
4J(H,H) = 2.5 Hz, 1 H, CHAr], 7.72 [d, 4J(H,H) = 2.5 Hz, 1 H,
CHAr], 7.49 (s, 2 H, CHAr), 7.17 (s, 4 H, CHAr), 7.11–7.09 (m, 2
General Procedure for the Reaction Profiling Studies: A NMR tube
equipped with a septum was charged with diethyl allyl(methallyl)-
malonate 8 (25 mg, 0.1 mmol) and CD2Cl2 or C2D4Cl2 (0.9 mL)
under argon. The sample was equilibrated at the required tempera-
ture in the NMR probe. The sample was locked and shimmed be-
fore the addition of the catalyst (100 µL, 1 µmol, 0.1 solution
of catalyst). The reaction progress was monitored by the periodic
acquisition of data over 1 h and integration of the characteristic
signals for the allylic proton resonances.
3
H, CHAr), 5.01 [sept., J(H,H) = 6.1 Hz, 1 H, CH(CH3)2], 2.50 (s,
3
12 H, CH3ortho), 2.26 (s, 6 H, CH3para), 1.34 [d, J(H,H) = 6.1 Hz,
6 H, CH(CH3)2] ppm. 13C NMR (100 MHz, [D6]acetone, 25 °C,
TMS): δ = 287.2 [d, J(C,Ru) = 12.4 Hz, CH=Ru], 174.2 (NCN),
149.6 (C=O), 145.2 (CAr), 139.5 (CAr), 139.2 (CAr), 137.9 (CAr),
136.2 (CAr), 131.5 (CAr), 129.2 (CHAr), 128.9 (CHAr), 125.3 (CHAr), Procedure for the Stability Studies: A Schlenk apparatus was filled
116.1 [q, J(C,F) = 286.7 Hz, CF3], 113.7 (CHAr), 113.3 (CHAr),
75.4 [CH(CH3)2], 20.7 (CH3), 20.3 (CH3), 18.4 (CH3) ppm. 19F
with the precatalyst (0.01 mmol) and the C6D6 solvent (5 mL) un-
der argon and then 1,7-octadiene (2 mmol, 300 µL) was added. Af-
Eur. J. Org. Chem. 2009, 4254–4265
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4263